scholarly journals THE CURRENT STATE OF THE U.S. PRIVATE LONG-TERM CARE INSURANCE INDUSTRY

2018 ◽  
Vol 2 (suppl_1) ◽  
pp. 449-450
Author(s):  
M Cohen
Author(s):  
Robert Klitzman

Insurers are rapidly gaining access to consumers’ genetic information. In the U.S., federal law bars using genetic information in health insurance, but not in life, disability, or long-term care insurance. Accordingly, insurers may fear adverse selection: individuals could undergo testing, learn they have risky genes, and purchase insurance without revealing test results. While other countries have established moratoria on insurers’ use of genetic information, there is no consensus in the U.S. regarding how to avoid ‘unfair discrimination.’ The chapter discusses alternative solutions, including government bans of insurers’ use of genetic information, or limiting insurer information to only high-risk genes.


Sign in / Sign up

Export Citation Format

Share Document